Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 1.000 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.704 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.629 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.588 | |
| 2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.558 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.547 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.543 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.537 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.534 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.519 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.514 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.514 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.505 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.502 | |
| 1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
| 4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.499 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.498 | |
| 1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.497 | |
| 2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.495 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.493 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.492 | |
| 4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.490 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.489 | |
| 1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.488 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.487 | |
| 1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.486 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
| 2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.485 | |
| 2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.483 | |
| 4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
| 1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.482 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
| 1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.479 | |
| 1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
| 2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.478 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.477 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.476 | |
| 3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
| 1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
| 1m2p | HNA | Casein kinase II subunit alpha | 2.7.11.1 | 0.473 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.473 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.473 | |
| 3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.471 | |
| 4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.471 | |
| 1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
| 2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.469 | |
| 3zm4 | 22T | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.468 | |
| 4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.468 | |
| 4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.466 | |
| 3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.466 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.466 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.465 | |
| 3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.464 | |
| 2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.462 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.461 | |
| 3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.461 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
| 2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
| 3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
| 3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
| 4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.460 | |
| 1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.459 | |
| 3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.459 | |
| 2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.458 | |
| 2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.458 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.458 | |
| 4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.457 | |
| 4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.457 | |
| 1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.456 | |
| 3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
| 2x2k | X2K | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.455 | |
| 3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.455 | |
| 4qna | X11 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 2eva | ADN | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.454 | |
| 2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
| 4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
| 1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.453 | |
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.453 | |
| 4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.453 | |
| 3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.452 | |
| 3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.452 | |
| 4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.452 | |
| 4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.452 | |
| 1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
| 2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.450 | |
| 2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
| 4ejn | 0R4 | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.450 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.450 | |
| 2gjn | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.449 | |
| 2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 3eyh | IZA | Tyrosine-protein kinase JAK1 | / | 0.449 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.448 | |
| 4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.448 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.447 | |
| 3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.447 | |
| 4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.447 | |
| 1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.446 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
| 2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.446 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.446 | |
| 2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.444 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.444 | |
| 3kc3 | MK2 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.444 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.444 | |
| 1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.443 | |
| 2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 2zoq | 5ID | Mitogen-activated protein kinase 3 | 2.7.11.24 | 0.443 | |
| 3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.443 | |
| 3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 3r83 | Z14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.443 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
| 3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
| 1dxo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.441 | |
| 1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4btj | ADP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.441 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.440 | |
| 2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.440 | |
| 4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.440 |